Data for: Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation

Published: 3 March 2019| Version 1 | DOI: 10.17632/93ngk2rn74.1
Contributors:
Nathalie Chazal, Laurence Briant, Serge Turcaud, Pascale Coric, Philippe Laugâa, Aymeric Neyret, Serge Bouaziz, Anais Cransac, Bernard Gay

Description

In silico docking of BVM and EP-39 on the hexameric crystal structure of the CACTD-SP1 Gag fragment

Files

Categories

Virology

Licence